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The pathologies of the pregnancy complications pre-eclampsia (PE) and fetal growth restriction (FGR) are
established in the ﬁrst trimester of human pregnancy. In a normal pregnancy, decidual spiral arteries are
transformed into wide diameter, non-vasoactive vessels capable of meeting the increased demands of
the developing fetus for nutrients and oxygen. Disruption of this transformation is associated with PE
and FGR. Very little is known of how these ﬁrst trimester changes are regulated normally and even less is
known about how they are compromised in complicated pregnancies. Interactions between maternal
and placental cells are essential for pregnancy to progress and this review will summarise the challenges
in investigating this area. We will discuss how ﬁrst trimester studies of pregnancies with an increased
risk of developing PE/FGR have started to provide valuable information about pregnancy at this most
dynamic and crucial time. We will discuss where there is scope to progress these studies further by
reﬁning the ability to identify compromised pregnancies at an early stage, by integrating information
from many cell types from the same pregnancy, and by improving our methods for modelling the
maternal-fetal interface in vitro.
© 2017 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
The events that occur at the maternal-fetal interface deﬁne the
success of a pregnancy yet are the most challenging to study.
Trophoblast invasion and remodelling of the uterine vasculature
occur in the ﬁrst trimester of pregnancy and are tightly regulated in
both a temporal and spatial manner. Information on the maternal-
fetal interface in the ﬁrst trimester can be gained from immuno-
histochemical studies however this does not give an indication of
which dynamic cellular andmolecular interactions are of functional
importance in regulating these crucial events. In this reviewwewill
discuss some of the strategies taken to investigate the ﬁeld, how
they have informed what we know about the cell biology of normal
pregnancies and those with placental complications and where the
scope for future development lies.2. Regulation of trophoblast invasion and spiral artery
remodelling
Trophoblast invasion occurs in a tightly regulated manner,t).
r Ltd. This is an open access article
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logy?, Placenta (2017), http:/inﬂuenced by signals from the surrounding decidual environment.
During the decidualisation process maternal immune cells are
recruited to the uterus in signiﬁcant numbers, with approximately
70% being decidual natural killer (dNK) cells, 20% macrophages and
the remaining 10% T cells. During placentation, extravillous
trophoblast (EVT) cells invade into the decidua and interact with
this enriched environment of specialised immune cells. Cross-talk
between the immune cells, stromal cells and the fetal EVT will
contribute to regulating EVT invasion and the accompanying
changes to the spiral artery structures required for successful
pregnancy.
Spiral artery remodelling involves the loss of vascular cells and
matrix proteins and occurs in an orchestrated fashion. The initial
steps involve activation and vacuolisation of endothelial cells (EC),
hypertrophy and disorganisation of vascular smooth muscle cells
(VSMC) and ﬁbrinoid deposition [1] while complete remodelling
requires EVTs [2]. Dramatic changes to the architecture of the spiral
arteries occur as they remodel in the ﬁrst trimester with cellular
events identiﬁed including: apoptosis of vascular cells, cellular
migration, de-differentiation and altered secretion of matrix
degrading enzymes. Following successful remodelling the resulting
high-ﬂow, low-resistance vessel is then capable of supplying suf-
ﬁcient blood to the intervillous space to meet the increasingunder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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ling is an early characteristic of common pregnancy complications
such as fetal growth restriction (FGR) and pre-eclampsia (PE) [3].
EVT invasion can be either interstitial or endovascular with
endovascular EVTs interacting directly with the ECwhile interstitial
EVT interact ﬁrst with the VSMCs. Invasion by either route will
inﬂuence vascular structure via disruption of the heterotypic in-
teractions between EC and VSMC known to be important for
maintaining a healthy differentiated vessel [4]. For example, dam-
age to the EC layer has been shown to results in VSMC de-
differentiation in other vessels [5]. It is noteworthy that even in
pregnancies with poor remodelling, trophoblasts plugs are present
and both endovascular and interstitial EVTs are seen. This would
suggest that failure to remodel cannot be explained by poor inva-
sion alone but also requires a failure of EVTs to interact appropri-
ately with the vascular cells.
There is increasing evidence that maternal immune cells in
addition to the fetal EVT play important roles in the remodelling
process. In humans all of the immune cell types are located around
actively remodelling vessels [6]. It is suggested that the immune
cells are involved in the changes that occur before the arrival of
trophoblast as well as regulating trophoblast-dependent remod-
elling [6e12]. For example leukocyte disruption of both EC and
VSMC was apparent before EVT were present [6] and processes
involving matrix degradation, vascular cell apoptosis and de-
differentiation have been implicated [11].
The ability to investigate during the timeframe in which these
changes are actively occurring is hindered by the difﬁculties
inherent in studying human pregnancy. A wide-ranging evaluation
of the cellular and molecular cross-talk at the maternal-fetal
interface, at what is the most critical time in the ﬁrst trimester,
therefore remains to be performed. Being able to develop strategies
to try and address this would advance our understanding of both
normal human pregnancy as well as pregnancies complicated by PE
and FGR.
3. When can we study the maternal-fetal interface?
Investigating vascular changes at a molecular or cellular level in
early human pregnancy is restricted by ethical issues and while
animals model some aspects of human pregnancy, they lack deep
trophoblast invasion and comparable spiral artery transformation
[13]. Some of the challenges in obtaining tissue are highlighted in
Fig. 1 on a timeline of gestation. All of these types of tissue can be
informative at different stages of pregnancy and have advantages
and disadvantages in what can be extrapolated from them
regarding events occurring in both normal and pathologic
pregnancy.
Access to human tissue is limited in ongoing pregnancies to that
obtained during chorionic villous sampling (CVS) for genetic
screening in the ﬁrst to early second trimester, or that obtained
following parturition. Some highly informative gene array studies
have been carried out on tissue obtained from CVS suggesting that
the decidual environment may be key in the establishment of
placental pathology [14,15]. A considerable advantage of these
studies is that the pregnancy can be followed to determinewhether
the woman develops any pregnancy complications or has a normal
pregnancy outcome [16]. The amount of tissue obtained is however
very small making it less amenable for cellular studies. Going for-
ward this may not continue to be a feasible approach as the use of
chorionic villous sampling as a diagnostic technique is diminishing
due to the increasing use of non-invasive prenatal testing [17].
Placental tissue obtained at term comes from a pregnancy
where it is known whether the woman developed PE or another
placental complication and has the advantage that tissue isPlease cite this article in press as: J.E. Cartwright, G.S. Whitley, Strategies
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resents a time many months after active remodelling has occurred
and any differences in the placentas of PE/FGR pregnancies may
represent a consequence of the disorder rather than inform caus-
ative pathology. To investigate the decidua and myometrium,
uterine biopsies can be taken at the time of delivery and histo-
chemical studies carried out or cells and vessels isolated. This
approach has proven useful in developing models of spiral artery
remodelling where non-placental bed vessels are obtained and
used in co-culture with EVT [18,19]. These vessels will not have
been in contact with EVT during pregnancy so can helpmodel some
aspects of the remodelling process however they will have been
changed by the non-EVT dependent remodelling [1] so are not
completely representative of the pre- and early pregnancy vessels.
Tissue samples can also be obtained following termination of
pregnancy in the ﬁrst trimester. The approach taken by our group
and others has been to focus on events occurring in the ﬁrst
trimester as this is the most informative time to study EVT invasion
and vessel remodelling. Most studies using ﬁrst trimester tissue
have been done without any additional information to inform
whether that pregnancy was developing normally. Herein lies the
challenge as the clinical symptoms of conditions such as PE are not
apparent until after 20 weeks gestation. How can we look at ﬁrst
trimester tissue and know whether it is from a normal or patho-
logic pregnancy? We have started to address this by using uterine
artery resistance index (RI) measurements obtained by Doppler
Ultrasound screening to identify women who would have had an
increased risk of pregnancy complications had the pregnancy
progressed, allowing us to divide the ﬁrst trimester placental and
decidual tissue into two study groups; that from pregnancies with a
higher risk and a very low risk of developing PE/FGR. A disadvan-
tage of this approach lies in the fact that many of the pregnancies
designated higher risk in the ﬁrst trimester would have ended up
progressing normally despite the probable initial impairment. This
will be addressed in the future studies section below. Even given
this limitation we have reported fundamental differences in the
behaviour of cells isolated from the fetal-maternal interface of high
resistance index (RI) compared to normal RI pregnancies whichwill
be described in the following section.
4. First trimester studies of pregnancies with an increased
risk of developing PE/FGR
Studies of approximately 10,000 ongoing pregnancies showed
that cases with a resistance index obtained from uterine artery
Doppler scanning of >95th percentile (high RI) had a 5-fold
increased risk of that pregnancy developing placental complica-
tions compared to those with a normal RI (<95th percentile) [20].
We have used this as a proxy measure of poor remodelling in the
ﬁrst trimester to separate tissue from ﬁrst trimester terminations of
pregnancy into normal RI (normal remodelling) and high RI groups
(poor remodelling). With advances in the development of tech-
niques to isolate cells from tissue with high purity and viability we
have been able to begin a more comprehensive proﬁling of these
pregnancies.
We have shown that primary trophoblast cells isolated from the
hRI pregnancies are more sensitive to apoptotic cell death than
those fromnRI pregnancies, and this may be a contributing factor to
impaired invasion [21]. Additionally when primary EVT were
grown out from chorionic villous explant cultures there were less
extensive outgrowths from the hRI group compared to the nRI
group (unpublished data). Additional evidence for impaired inva-
sion/remodelling comes from immunohistochemical studies
showing that there are fewer trophoblast plugs present in the spiral
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Fig. 1. Tissue accessibility at different stages of pregnancy. The tissue available at termination of pregnancy (TOP), chorionic villous sampling (CVS) or at parturition (birth) are
shown (grey boxes). The limitations and advantages of what can be studied from tissue obtained at these times is summarised (white boxes). Pre-eclampsia is shown as being
detected clinically after approximately 20 weeks gestation.
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placental tissue from these groups has shown differential expres-
sion of genes related to immune and inﬂammatory responses [20].
Differences in how the maternal immune cells behave between
these patient groups is also starting to become clearer with dNK
cells from pregnancies with impaired remodelling showing ab-
normalities in secreted proteins and functional interactions with
other decidual cells [7,8,23e25]. For example, dNK cells from nRI
pregnancies promote more trophoblast chemotaxis, motility and
invasion than those from hRI pregnancies [24], and dNK from hRI
pregnancies are less able to activate some of the pro-invasive sig-
nalling pathways in trophoblast such as ERK1/2 and Akt [24]. We
have demonstrated that the expression of receptors involved in
regulating dNK cell effector function differs in the patient groups
with KIR2DL/S1,3,5 and LILRB1 (ILT-2) positive dNK cells decreased
in pregnancies with a hRI [25]. While the functional outcome of this
remains to be determined, at least in the case of LILRB1, this leads to
a difference in dNK cell expression of factors that can regulate
trophoblast migration/invasion [24].
There is evidence for the involvement of dNK cells directly in
spiral artery remodelling [6,10,11,26]. We have shown that dNK
cells can induce vascular cell apoptosis and destabilise vessel
structures, events of importance in spiral artery changes and that
dNK cells from the hRI pregnancies were less able to do this [7,8].
It is clear that studying the uterine artery Doppler screened
patient groups, combined with improved techniques for isolating
pure cell types and modelling events in vitro, has increased our
knowledge of how placentation in the ﬁrst trimester develops
normally and pathologically. There is however scope for much
development of these areas in the future, which will be addressed
in the following section.5. Future directions
Improvements in early diagnostic tools are proving valuable
clinically, for example reliable serum or metabolic biomarkers that
more accurately predict development of PE before the clinical
symptoms become apparent [27]. Adding supplementary criteria toPlease cite this article in press as: J.E. Cartwright, G.S. Whitley, Strategies
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tissue we have described above, would much improve the ability to
predict PE risk. This raises the intriguing possibility of investigating
subgroups within the hRI group. Evidence suggests that there are
impairments in EVT behaviour and spiral artery remodelling in the
hRI group [21,22]. Further deﬁnition of this group may allow us to
study ﬁrstly those with a very high likelihood of developing PE and
secondly those where the initial impairment in remodelling is not
sufﬁcient to lead to the clinical condition. In this second group we
could postulate that this is because remodelling was merely
delayed and there are compensatory mechanisms which overcome
this (here the considerable overlapping roles that fetal trophoblast
and the maternal immune cells have during remodelling may be
highly relevant). Additionally there are likely to be inherent dif-
ferences in how different mothers respond to factors produced by
an intermittently perfused and stressed placenta, perhaps reﬂect-
ing differences at a cardiovascular level [28]. This group is partic-
ularly interesting as it may help us to deﬁne how some women are
more able to tolerate or compensate for early problems. It is only
when we can grasp this that we can consider how we might ther-
apeutically make one of the groups resemble the other in outcome.
This is summarised in Fig. 2.
The complexities of modelling cellular interactions in a more 3-
dimensional (3D) environment also provide challenges and po-
tential for development. Immunohistochemical studies can provide
much information about early human pregnancy however in vitro
culture systems are needed to look at dynamic multi-cellular in-
teractions. Some of the general processes involved in spiral artery
remodelling have been reported by a number of groups, including
our own, using monolayer co-cultures [29] and explant cultures
[18,30], and have revealed roles for EVT-dependent apoptotic
vascular cell loss [19,31], VSMC de-differentiation [32] and
disruption of cellular interactions through proteases [33]. Growing
vascular cells in a 3D spheroidal model that recapitulates EC/VSMC
interactions seen in vivo allowed us to determine which genes were
differentially expressed following stimulation by trophoblast and
show VSMC de-differentiation [34]. The future application of some
of the newer 3D technologies, many of which stem fromfor investigating the maternal-fetal interface in the ﬁrst trimester of
/dx.doi.org/10.1016/j.placenta.2017.05.003
Fig. 2. Scope for further reﬁnement of the uterine artery Doppler screened ﬁrst
trimester patient groups. Women with a ﬁrst trimester uterine artery Doppler
resistance index (RI) > 95th percentile (high RI) had a 5-fold increased risk of that
pregnancy developing placental complications of pregnancy compared to those with a
normal RI (<95th percentile). We have used this as a proxy measure of poor remod-
elling in the ﬁrst trimester to separate tissue from ﬁrst trimester terminations of
pregnancy into normal RI (normal remodelling) and high RI groups (poor remodelling).
However even in the high RI group the majority of these women would not develop
pregnancy complications had the pregnancy progressed. With the addition of other
markers to further deﬁne the high RI group wewill be able to investigate how an initial
impairment in remodelling can be compensated for. In addition we can start to deﬁne
the relative contribution of placental/decidual differences and how much of the
endpoint is determined by the maternal response to a stressed placenta. The arrows
with queries represent areas for possible therapeutic strategies to reverse the pa-
thology once more is understood regarding the cellular and molecular events.
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placental and decidual modelling. These developments include
sophisticated synthetic matrices and scaffolds and approaches such
as Real Architecture for 3D tissues (RAFT) technology [35].
Advances in isolation and culture methods for primary cells
means that multiple cell types can be isolated from ﬁrst trimester
tissue from an individual pregnancy. We routinely isolate stromal
cells, dNK cells andmacrophages as well as endothelial cells (which
will include those from spiral arteries) from decidual tissue of the
uterine artery Doppler screened women. From the placenta we can
isolate trophoblast, stromal, endothelial and macrophages. In the
future the ability to look at multiple cell types across an individual
pregnancy (with a known risk of developing complications) pro-
vides an opportunity for some complex proﬁling integrating in-
formation about genes, microRNAs, proteome and secretome with
readouts from functional and biochemical cell based assays. This
will allow us to start to get an overview of the maternal-fetal
interface in an individual pregnancy. Determining whether this
complex information can be integrated to model both normal and
PE pregnancies will require strong collaborations with the bioin-
formatics and mathematical modelling ﬁelds. We will then be able
to interrogate these models asking questions such as the impor-
tance of particular cellular or molecular interactions to successful
placentation. The ultimate aim of developing robust models of the
maternal-fetal interface would be to help in the identiﬁcation of
novel targets and the safe design of therapies.
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